Insights
Keep up with the latest news, insights and events from Norstella and its market-leading brands
- Article
Real-world data in 2025 and beyond: Closing the strategy gap
Pharma leaders agree that real-world data (RWD) is essential—but many still struggle to harness its full potential. In Real-World Data in 2025 and Beyond: Closing the Strategy Gap, Norstella surveyed 200 life sciences executives to uncover how organizations are using RWD, where they’re falling short,…
- Article
Pharma’s real-world data dilemma: Strategic asset or wasted resource?
Every day, patients are experiencing the life-changing impact of real-world data (RWD), and life sciences companies are feeling the business impact, too. RWD is no doubt helping pharma companies better understand the patient journey and get life-saving therapies to market faster, according to Norstella’s recent…
- Article
The growing strategic influence of market access
Market access professionals tell us that their role is becoming increasingly influential amid a turbulent policy environment and intense competitive landscape. This was one of the clearest results from a survey commissioned by MMIT and The Dedham Group, which we explored in a recent white…
- Article
The R&D implications of market access complexity
Our latest research strongly suggests that a highly dynamic market access situation in the US is feeding back into upstream decisions around R&D strategy. We explored this topic in detail in a recent white paper called Working Backwards: Patient access strategy is now guiding R&D….
Work with us
Join our mission
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Get in touch
Let's connect
Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?